位置:首页 > 蛋白库 > RBA1_ARATH
RBA1_ARATH
ID   RBA1_ARATH              Reviewed;         363 AA.
AC   F4HT77; Q9FX07;
DT   11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 1.
DT   03-AUG-2022, entry version 60.
DE   RecName: Full=Disease resistance protein RBA1 {ECO:0000305};
DE   AltName: Full=NAD(+) hydrolase RBA1;
DE            EC=3.2.2.6 {ECO:0000269|PubMed:31439793};
DE   AltName: Full=NADP(+) hydrolase RBA1 {ECO:0000305};
DE            EC=3.2.2.- {ECO:0000269|PubMed:31439793};
DE   AltName: Full=Response to HopBA1 protein {ECO:0000303|PubMed:28137883};
DE            Short=RBA1 {ECO:0000303|PubMed:28137883};
GN   Name=RBA1 {ECO:0000303|PubMed:28137883};
GN   OrderedLocusNames=At1g47370 {ECO:0000312|EMBL:AEE32160.1};
GN   ORFNames=T3F24.3 {ECO:0000312|EMBL:AAG11420.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S., White O.,
RA   Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y., Buehler E.,
RA   Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W., Chung M.K., Conn L.,
RA   Conway A.B., Conway A.R., Creasy T.H., Dewar K., Dunn P., Etgu P.,
RA   Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y., Gill J.E., Goldsmith A.D.,
RA   Haas B., Hansen N.F., Hughes B., Huizar L., Hunter J.L., Jenkins J.,
RA   Johnson-Hopson C., Khan S., Khaykin E., Kim C.J., Koo H.L.,
RA   Kremenetskaia I., Kurtz D.B., Kwan A., Lam B., Langin-Hooper S., Lee A.,
RA   Lee J.M., Lenz C.A., Li J.H., Li Y.-P., Lin X., Liu S.X., Liu Z.A.,
RA   Luros J.S., Maiti R., Marziali A., Militscher J., Miranda M., Nguyen M.,
RA   Nierman W.C., Osborne B.I., Pai G., Peterson J., Pham P.K., Rizzo M.,
RA   Rooney T., Rowley D., Sakano H., Salzberg S.L., Schwartz J.R., Shinn P.,
RA   Southwick A.M., Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M., Wu D.,
RA   Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, INDUCTION, ACTIVE SITE, AND
RP   MUTAGENESIS OF 31-SER-HIS-32; SER-31; HIS-32; LYS-149 AND GLY-151.
RX   PubMed=28137883; DOI=10.1073/pnas.1620973114;
RA   Nishimura M.T., Anderson R.G., Cherkis K.A., Law T.F., Liu Q.L.,
RA   Machius M., Nimchuk Z.L., Yang L., Chung E.H., El Kasmi F., Hyunh M.,
RA   Osborne Nishimura E., Sondek J.E., Dangl J.L.;
RT   "TIR-only protein RBA1 recognizes a pathogen effector to regulate cell
RT   death in Arabidopsis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E2053-E2062(2017).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND MUTAGENESIS OF GLU-86.
RX   PubMed=31439793; DOI=10.1126/science.aax1771;
RA   Wan L., Essuman K., Anderson R.G., Sasaki Y., Monteiro F., Chung E.H.,
RA   Osborne Nishimura E., DiAntonio A., Milbrandt J., Dangl J.L.,
RA   Nishimura M.T.;
RT   "TIR domains of plant immune receptors are NAD+-cleaving enzymes that
RT   promote cell death.";
RL   Science 365:799-803(2019).
CC   -!- FUNCTION: Disease resistance (R) protein that specifically recognizes
CC       the HopBA1 type III effector protein from P.syringae, and triggers cell
CC       death (PubMed:28137883). Acts as a NAD(+) hydrolase (NADase): in
CC       response to pathogen-recognition, catalyzes cleavage of NAD(+) into
CC       ADP-D-ribose (ADPR) and nicotinamide; NAD(+) cleavage triggering a
CC       defense system that promotes cell death (PubMed:31439793). In addition
CC       to ADPR, also generates a cyclization variant of cyclic ADPR (cADPR),
CC       termed v-cADPR, for which the cyclizing bond is unknown
CC       (PubMed:31439793). Also able to hydrolyze NADP(+), but not other
CC       NAD(+)-related molecules (PubMed:31439793).
CC       {ECO:0000269|PubMed:28137883, ECO:0000269|PubMed:31439793}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000269|PubMed:31439793};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000269|PubMed:31439793};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NADP(+) = ADP-D-ribose 2'-phosphate + H(+) +
CC         nicotinamide; Xref=Rhea:RHEA:19849, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:58673; Evidence={ECO:0000269|PubMed:31439793};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19850;
CC         Evidence={ECO:0000269|PubMed:31439793};
CC   -!- SUBUNIT: Homooligomer; homooligomerization is required for activity.
CC       {ECO:0000269|PubMed:28137883, ECO:0000269|PubMed:31439793}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28137883}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:28137883}. Note=Forms aggregate-like
CC       cyto-nucleoplasmic puncta. {ECO:0000269|PubMed:28137883}.
CC   -!- INDUCTION: Accumulates during immune responses activated by a variety
CC       of NLR proteins. {ECO:0000269|PubMed:28137883}.
CC   -!- DOMAIN: The TIR domain catalyzes the NAD(+) cleavage (NADase) activity
CC       (PubMed:31439793). In contrast to classical TIR-NB-LRR receptor-like
CC       proteins, only contains a TIR domain (Probable).
CC       {ECO:0000269|PubMed:31439793, ECO:0000305}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000255|PROSITE-ProRule:PRU00204}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG11420.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC015449; AAG11420.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE32160.1; -; Genomic_DNA.
DR   PIR; D96514; D96514.
DR   RefSeq; NP_175170.1; NM_103631.1.
DR   AlphaFoldDB; F4HT77; -.
DR   SMR; F4HT77; -.
DR   STRING; 3702.AT1G47370.1; -.
DR   PaxDb; F4HT77; -.
DR   PRIDE; F4HT77; -.
DR   EnsemblPlants; AT1G47370.1; AT1G47370.1; AT1G47370.
DR   GeneID; 841140; -.
DR   Gramene; AT1G47370.1; AT1G47370.1; AT1G47370.
DR   KEGG; ath:AT1G47370; -.
DR   Araport; AT1G47370; -.
DR   TAIR; locus:2203776; AT1G47370.
DR   eggNOG; KOG0619; Eukaryota.
DR   HOGENOM; CLU_763668_0_0_1; -.
DR   InParanoid; F4HT77; -.
DR   OrthoDB; 1766717at2759; -.
DR   PRO; PR:F4HT77; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; F4HT77; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:TAIR.
DR   GO; GO:0050135; F:NAD(P)+ nucleosidase activity; IDA:UniProtKB.
DR   GO; GO:0003953; F:NAD+ nucleosidase activity; IDA:UniProtKB.
DR   GO; GO:0061809; F:NAD+ nucleotidase, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0052542; P:defense response by callose deposition; IMP:TAIR.
DR   GO; GO:0019677; P:NAD catabolic process; IDA:UniProtKB.
DR   GO; GO:0034052; P:positive regulation of plant-type hypersensitive response; IMP:TAIR.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 3.40.50.10140; -; 1.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   Pfam; PF01582; TIR; 1.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF52200; SSF52200; 1.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Hydrolase; NAD; Nucleus; Plant defense; Reference proteome.
FT   CHAIN           1..363
FT                   /note="Disease resistance protein RBA1"
FT                   /id="PRO_0000448795"
FT   DOMAIN          12..175
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   ACT_SITE        86
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204,
FT                   ECO:0000305|PubMed:31439793"
FT   BINDING         21..26
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:V9M398"
FT   BINDING         53
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:V9M398"
FT   MUTAGEN         31..32
FT                   /note="SH->AA: Decreased ability to induce cell death due
FT                   to impaired homooligomerization."
FT                   /evidence="ECO:0000269|PubMed:28137883"
FT   MUTAGEN         31
FT                   /note="S->A: Decreased ability to induce cell death."
FT                   /evidence="ECO:0000269|PubMed:28137883"
FT   MUTAGEN         32
FT                   /note="H->A: Abolished ability to induced cell death."
FT                   /evidence="ECO:0000269|PubMed:28137883"
FT   MUTAGEN         86
FT                   /note="E->A: Loss of NAD(+) hydrolase activity."
FT                   /evidence="ECO:0000269|PubMed:31439793"
FT   MUTAGEN         149
FT                   /note="K->E: Decreased ability to induce cell death due to
FT                   impaired homooligomerization."
FT                   /evidence="ECO:0000269|PubMed:28137883"
FT   MUTAGEN         151
FT                   /note="G->R: Abolished ability to induce cell death."
FT                   /evidence="ECO:0000269|PubMed:28137883"
SQ   SEQUENCE   363 AA;  42118 MW;  850F477F21D01ACB CRC64;
     MTSVSPRYRN VPVPKVFLSF RGEEIRHGFI SHLADALERY GIMFIIDKDE QRGNDLTSLL
     LRIKESKVAL VIFSSRFAES RFCMDEIVKM KECVDERKLL VIPIFYKVRA RDVSGRTGDF
     GKKFWALAQK SRGCQIKEWM EALECISNKM GLSLGDGRSE ADFIKEIVKE VERVLATFTS
     EDTEDHHCQT VKLLKGLVVG CLAHQELPLV LVFTQVYYYV KFSIFFIEEI FSSCFRKGFV
     LKPCKEDLQI NSISIPGIDL ENFKNMMQQA MYELNQMLLQ SLGNIDPHRD VAFENQPQDQ
     PDSPIALPEE RRVALEATKF CGHAAYWWNQ TKTTRARIGK VLIHFWEKLK KKFKDTYDRT
     VRI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024